| __timestamp | Amgen Inc. | Travere Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 4699000000 | 59644696 |
| Thursday, January 1, 2015 | 4846000000 | 79541000 |
| Friday, January 1, 2016 | 5062000000 | 98015000 |
| Sunday, January 1, 2017 | 4870000000 | 103958000 |
| Monday, January 1, 2018 | 5332000000 | 103654000 |
| Tuesday, January 1, 2019 | 5150000000 | 128951000 |
| Wednesday, January 1, 2020 | 5730000000 | 135799000 |
| Friday, January 1, 2021 | 5368000000 | 149883000 |
| Saturday, January 1, 2022 | 5414000000 | 220206000 |
| Sunday, January 1, 2023 | 6179000000 | 265542000 |
| Monday, January 1, 2024 | 7096000000 |
Cracking the code
In the ever-evolving landscape of biotechnology, effective cost management is crucial for sustaining growth and innovation. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of two prominent players: Amgen Inc. and Travere Therapeutics, Inc., from 2014 to 2023. Over this period, Amgen's SG&A expenses have shown a steady increase, peaking at approximately $6.2 billion in 2023, marking a 31% rise from 2014. In contrast, Travere Therapeutics, while smaller in scale, has experienced a significant surge in SG&A expenses, growing by over 345% to reach around $265 million in 2023. This stark contrast highlights the diverse strategies employed by these companies in managing operational costs. As the biotech sector continues to expand, understanding these financial dynamics offers valuable insights into the strategic priorities and market positioning of industry leaders.
Operational Costs Compared: SG&A Analysis of Johnson & Johnson and Amgen Inc.
Who Optimizes SG&A Costs Better? Amgen Inc. or Walgreens Boots Alliance, Inc.
Comparing SG&A Expenses: Amgen Inc. vs TG Therapeutics, Inc. Trends and Insights
Breaking Down SG&A Expenses: Amgen Inc. vs Viking Therapeutics, Inc.
Breaking Down SG&A Expenses: Amgen Inc. vs Merus N.V.
Operational Costs Compared: SG&A Analysis of Amgen Inc. and Soleno Therapeutics, Inc.
SG&A Efficiency Analysis: Comparing Summit Therapeutics Inc. and Travere Therapeutics, Inc.
SG&A Efficiency Analysis: Comparing Corcept Therapeutics Incorporated and Travere Therapeutics, Inc.
Cost Management Insights: SG&A Expenses for Ionis Pharmaceuticals, Inc. and Travere Therapeutics, Inc.
Selling, General, and Administrative Costs: Verona Pharma plc vs Travere Therapeutics, Inc.
Breaking Down SG&A Expenses: MannKind Corporation vs Travere Therapeutics, Inc.
SG&A Efficiency Analysis: Comparing Amphastar Pharmaceuticals, Inc. and Travere Therapeutics, Inc.